Transfusion Medicine Market Competitive Landscape, 2019-2023: Strategic Assessments of Leading Suppliers
This report presents extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. For each company the report provides:
- Sales
- Market shares
- Product portfolios
- Marketing tactics
- Technological know-how
- New products in R&D
- Collaborative arrangements
- Business strategies
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- CellMark Forensics/LabCorp
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Immucor
- Ortho-Clinical Diagnostic
- Proteome Sciences
- Quest
- Quidel
- Roche
- Siemens
- Tecan
- Thermo Fisher
Europe Transfusion Diagnostics Market for over 40 Immunohematology and NAT Tests, 2019-2023: France, Germany, Italy, Spain, UK--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers
This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years,
View ReportBlood Bank Instrumentation: Transfusion Diagnostic Testing Analyzers and Strategic Profiles of Leading Suppliers, 2019
This 68-page report reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers.The report also presents strategic assessments of current and emerging suppliers of transfusion
View ReportNorth America Nephropathy medicine Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
Abstract:The North America Nephropathy medicine market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by
View ReportGlobal Nephropathy medicine Market Report 2019 - Market Size, Share, Price, Trend and Forecast
The global market size of Nephropathy medicine is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end
View ReportFill The Form For Sample Request